Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office

Novel Composition of MDMA Enantiomers leading to next-generation MDMA possibilitiesTORONTO, March 27, 2024 -- PharmAla Biotech Holdings Inc. , a biotechnology company focused on the research,...

Related Keywords

Canada ,Sydney ,New South Wales ,Australia ,Toronto ,Ontario ,Canadian ,Nicholas Kadysh ,Harpreet Kaur ,Nick Kadysh ,Trademark Office ,Regulation Services Provider ,Pharmala Biotech Holdings Inc ,Neither The Canadian Securities Exchange ,Drug Administration ,University Of Sydney ,Research At Pharmala Biotech ,Novel Composition ,Ala Biotech Holdings ,Chemical Entity ,General Population ,Vice President ,Novel Chemical Entity ,Active Moiety ,Data Exclusivity ,Social Anxiety ,Autism Spectrum Disorder ,Orphan Indication ,Intellectual Property Ontario ,Canadian Securities Exchange ,Markets ,